An opportunity for Korean pharmaceutical and biopharma companies to be one step closer to entering European market
Find out why Switzerland is a world leading hub for open innovation and R&D cooperation for pharma/bio-pharma industry.
Switzerland is a world leading innovation hub for pharma/bio-pharma industry. As a home for top-tier global pharmaceutical companies including Norvatis and Roche, Switzerland has achieved continuous innovation through open innovation among research/medical institutions, global companies and start-ups for a long time.
Highly developed infrastructure, talented workforce in pharma/bio-pharma sector and the A to Z value chain across the industry provide an ideal ecosystem for foreign pharma/bio companies to conduct activities like strategic partnership, licensing in/out, and patent transaction.
The core advantages of Swiss life science cluster are; 1) Innovative R&D collaboration opportunity with global pharma/bio-pharma companies and startups 2) Life science specialized talents, 3) Stable environment nurturing globally successful start-ups.
If you are currently planning to expand your business into Europe and consider Switzerland as a new business location or innovative open innovation R&D partner, please register for our webinar. We hope that this webinar provides an opportunity for Korean pharmaceutical and biopharma companies to be one step closer to entering European market.
|Korean companies planning to expand into European market and/or seek R&D open innovation with Switzerland (C-level and manager level recommended)
|Swiss Business Hub Korea, Switzerland Innovation
ZOOM link to be provided after RSVP. This webinar is to be recorded for internal use only
Online (Korean Standard Time / Simultaneous interpretation will be provided.)